-
2
pagini
-
English
-
Documente
Descriere
Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis PR Newswire CORK, Ireland and SPRING HOUSE, Pennsylvania, Aug. 23, 2012 CORK, Ireland and SPRING HOUSE, Pennsylvania, Aug.
-
Publicat de
-
Limba
English